Aileron Therapeutics Inc. (ALRN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 9:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -0.89 | -0.4 | -1.94 | -1.66 | -0.49 | -0.39 | -3.47 | -6.5 | -9.15 | -0.26 | 21.15 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.18 |
PB Ratio | 2.04 | 0.58 | 1.14 | 2.98 | 0.88 | 0.63 | 1.64 | -1.05 | -1.25 | 0.26 | 0.36 |
P/FCF Ratio | -0.71 | -0.43 | -2.09 | -1.77 | -0.53 | -0.38 | -3.79 | -7.85 | -9.99 | -0.23 | -0.29 |
P/OCF Ratio | -0.71 | -0.43 | -2.1 | -1.77 | -0.53 | -0.44 | -3.82 | -7.85 | -10.07 | -0.24 | -0.29 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.63 |
Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 0.03 | 0.31 | 0.27 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 4.17 | 6.46 | 10.69 | 4.12 | 3.35 | 4.05 | 10.60 | 5.18 | 1.58 | 8.09 | 3.37 |
Current Ratio | 4.17 | 6.46 | 10.69 | 4.12 | 3.35 | 4.05 | 10.60 | 5.18 | 1.58 | 8.09 | 3.37 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.39 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -2.28 | -1.45 | -0.59 | -1.79 | -1.79 | -1.61 | -0.47 | 0.16 | 0.14 | -1.03 | 0.02 |
Return on Assets (ROA) | -0.15 | -1.23 | -0.53 | -1.34 | -1.09 | -1.04 | -0.43 | -0.82 | -2.17 | -0.91 | 0.01 |
Return on Capital (ROIC) | -0.16 | -1.48 | -0.61 | -1.66 | -1.45 | -1.28 | -0.48 | -1.01 | -3.8 | -1.03 | 0.28 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45.29% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.87% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.72% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.69% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -63.55% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.16% |